About Renaissance BioScience
Renaissance BioScience is a Healthcare company based in Vancouver (Canada) founded in 2013 by John Husnik. It operates as a yeast strains are developed through classical and selective breeding techniques. It operates on a Professional Services model. Renaissance BioScience has raised $5 million across 3 funding rounds from investors including National Research Council Canada and Canadian Food Innovation Network. The company has 17 employees. Its chief executive is John Husnik. Renaissance BioScience offers products and services including Bioengineering Solutions and Gene-Targeted Products. Its focus areas include Biotechnology, Agricultural Biotechnology, Biopesticides and Biocontrol and Health Biotechnology. Its legal entity is Renaissance BioScience Corp. Its competitors include Benson Hill, Cibus, Pairwise, Inari and Ceres and 2 more; 6 of its 7 listed competitors have raised funding.
Company details
Innovative bioengineering solutions are developed by Renaissance BioScience for multiple industries. Whole organism and gene-targeted engineering technologies are utilized to create products and solutions. Sectors such as agriculture, food and beverages, health and pharmaceuticals, and industrial products are served. Applications include biopesticides, animal wellness, probiotics, nutritional supplements, flavors, fragrances, and biofuels. Sustainable and smarter production methods are prioritized to benefit millions globally.
- Headquarters Vancouver, Canada
- Employees 17
- Founders John Husnik
- SectorsHealthcare
- Phone•••• ••••
- Website renaissancebioscience.com
- Social LinkedIn
- Legal Name Renaissance Bioscience Corp.
- Total Equity Funding$5M (USD)
in 3 rounds
- Latest Funding Round$172.32K (USD), Grant
Feb 2024
- InvestorsNational Research Council Canada
& 1 more
- Employee Count17
Products & Services of Renaissance BioScience
Renaissance BioScience offers a comprehensive portfolio of products and services, including Bioengineering Solutions and Gene-Targeted Products.
Solutions are developed using whole organism engineering technology.
Products are created through targeted genetic engineering methods.
Funding Insights of Renaissance BioScience
Renaissance BioScience has successfully raised a total of $5M across 3 strategic funding rounds. The most recent funding activity was a Grant round of $172.32 thousand completed in February 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $5M
- Total Rounds 3
- Last Round Grant — $172,315
- First Round $370,000
(Jun 2017)
- Investors Count 2
All 3 funding rounds of Renaissance BioScience with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb 2024 | $172,315 | Grant | – | – | |
| Nov 2021 | $5M | Series A | – | – | – |
| Jun 2017 | $370,000 | Grant | – | – |
2 investors in total: 2 institutional.
Investors in Renaissance BioScience
Renaissance BioScience has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include National Research Council Canada and Canadian Food Innovation Network.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
A network for food innovation in Canada is facilitated. | – | cfin-rcia.ca | Canada | |
Scientific and technological research is conducted for Canada's benefit. | 1916 | nrc.canada.ca | Ottawa, Canada |
Investor details for Renaissance BioScience
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Renaissance BioScience
1 people are tracked at Renaissance BioScience (1 in leadership); the tracked headcount is 17.
| Name | Role | Group |
|---|---|---|
John Husnik | Co-Founder & CEO | Leadership |
Complete people profiles for Renaissance BioScience
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Renaissance BioScience
3 dated milestones of Renaissance BioScience across 11 years, from founding to its latest funding, stage changes and deals.
- Founded Renaissance BioScience is founded.
- Funding First funding round of $370K.
- Funding Latest funding round, Grant, of $172K.
Competitors of Renaissance BioScience
Renaissance BioScience has 7 listed competitors in our database, 6 of them funded. They include Benson Hill, Cibus, Pairwise, Inari and Ceres, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| bensonhill.com | 2012 | St. Louis, United States | $406.99M | 151 | Provider of plant-based food ingredients | |
| cibus.com | 2001 | San Diego, United States | $34.47M | 129 | Gene editing solutions are provided for agriculture. | |
| pairwise.com | 2017 | Durham, United States | $155M | – | New crop varieties are developed using gene-editing for agrigenomics. | |
| inari.com | 2016 | Cambridge, United States | $708M | 143 | Breeding technology is provided by Inari to design seeds. | |
| ceres.com | 1996 | Milan, Italy | – | – | Beers are produced and branded by Ceres in Italy. | |
| limagrain.com | 1965 | Clermont Ferrand, France | $200M | – | Production and distribution of GM and non-GMO seeds and other farm inputs | |
| hifidelitygenetics.com | 2014 | Durham, United States | $8.5M | 1 | Developer of a predictive breeding platform to identify crop traits and build crop models |
Detailed competitors of Renaissance BioScience
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Renaissance BioScience
The website of Renaissance BioScience (renaissancebioscience.com) receives about 1.3K visits a month.
- Monthly visits1.3K
▼ 22.3% vs previous month
Top companies in Genomics & Gene Therapy Platforms
10 companies that operate in the same segment as Renaissance BioScience (Genomics & Gene Therapy Platforms), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.34 B | USD 301.49 M | 1,372 | |
Provider of genetic test solutions to study ancestry, genealogy, and inherited traits | 2006 | Sunnyvale, California, United States | USD 943.53 M | USD 189.9 M | 562 | |
Provider of DNA testing services to create a family tree and ancestor | 2003 | Yehud, Central District, Israel | USD 40 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Gene therapies for rare diseases including retinal dystrophies are developed. | 2013 | Philadelphia, Pennsylvania, United States | USD 82.8 M | USD 64.73 M | 822 | |
Therapeutics for genetic diseases are developed through targeted interventions. | 2015 | Palo Alto, California, United States | USD 434.2 M | USD 502.08 M | 730 | |
Provider of an online genealogy platform offering a host of services | 1996 | Lehi, Utah, United States | USD 146.2 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Renaissance Bioscience
Complete news archive for Renaissance BioScience
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Renaissance BioScience
Renaissance BioScience was founded in 2013 and raised its 1st funding round 4 years after it was founded.
Renaissance BioScience is headquartered in Vancouver, Canada. It is registered at Vancouver, British Columbia, Canada.
John Husnik is the current CEO of Renaissance BioScience. They have also founded this company.
Renaissance BioScience is a funded company, having raised a total of $5M across 3 funding rounds to date. The company's 1st funding round was a Grant of $370K, raised on Jun 2017.
Renaissance BioScience has 17 employees.
Innovative bioengineering solutions are developed by Renaissance BioScience for multiple industries. Whole organism and gene-targeted engineering technologies are utilized to create products and solutions. Sectors such as agriculture, food and beverages, health and pharmaceuticals, and industrial products are served. Applications include biopesticides, animal wellness, probiotics, nutritional supplements, flavors, fragrances, and biofuels. Sustainable and smarter production methods are prioritized to benefit millions globally.
Renaissance BioScience's top competitors include Benson Hill, Cibus and Inari.
Renaissance BioScience offers Bioengineering Solutions and Gene-Targeted Products.
Renaissance BioScience has 2 investors. Key investors include National Research Council Canada, and Canadian Food Innovation Network.
Renaissance BioScience operates through Renaissance Bioscience Corp..